Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows

New research shows that a treatment plan based on a novel combination of low doses of three anti-hypertensive drugs in a single pill—known as GMRx2—was superior to a high-quality standard care treatment plan at lowering blood pressure in patients with uncontrolled hypertension.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup